UK Life Sciences Company Directory

Autophagy-enhancing small molecule drugs for neurodegeneration and rare disease

Samsara Therapeutics is a drug discovery company developing first-in-class small molecule therapeutics that restore autophagy, the cellular process of degrading and recycling damaged proteins, which declines with age and is dysfunctional in multiple diseases. Its platform identifies and chemically optimises…

National institute researching dementia and neurodegenerative disease across the UK

The UK Dementia Research Institute is the UK's leading national institute dedicated to transforming outcomes for people affected by dementia and neurodegenerative conditions. Its central Hub at University College London coordinates seven research Centres hosted across leading UK universities, working towards new…

3D cell culture scaffolds and human tissue services for drug research

REPROCELL is a life science company combining proprietary 3D cell culture products with ex vivo human tissue testing services for the pharmaceutical industry. Its scaffold enables cells to grow in three-dimensional structures that more closely replicate in vivo tissue behaviour, supporting drug safety, efficacy, and…

Contract development and manufacture of nanofibrous biomaterials for medical devices

The Electrospinning Company designs, develops, and manufactures nanofibrous biomaterials for implantable medical devices and regenerative medicine applications. Using electrospinning technology, the company produces four proprietary membrane platforms: resorbable Mimetix, permanent Kalyptix, biosynthetic Symatix, and…

NANOSTACKS organ models for preclinical drug safety research

Revivocell is a Lancaster University spin-out developing modular human microphysiological systems for preclinical drug discovery and toxicology. Its NANOSTACKS platform uses stackable cell-culture modules to assemble multilayer tissue models, including liver, neuronal and interconnected organ systems. The company…

Clinical-stage CNS drug discovery using human brain genomics

Cerevance is a clinical-stage biotechnology company developing small molecule therapeutics for neurodegenerative and psychiatric disorders. The company uses its proprietary platform to profile gene expression in specific neuronal and glial cell types from a collection of over 16,000 annotated human brain tissue…

Topical formulations treating atopic dermatitis and inflammatory skin disease

Quodria is a dermatology-focused biotech developing novel topical formulations for skin diseases using nanotechnology-enabled drug delivery. Its lead programme, Q001, is a small molecule galectin-3 inhibitor licensed from University of Liverpool spin-out Galytx, in development as a first-in-class topical treatment for…

AI platform for pharma drug discovery workflows

DaltonTx is a technology company building adaptive AI-enabled discovery platforms for the pharmaceutical industry. Its disease- and modality-agnostic platform integrates into pharma, biotech and CRO workflows, supporting both small molecule and biologics discovery through a self-learning system that improves with…

Animal health medicines and APIs manufactured for global markets

Elanco UK is the principal UK subsidiary of Elanco Animal Health Incorporated, a global animal health company developing and manufacturing products for farm animals and pets. Its primary UK manufacturing site in Speke, Liverpool produces fermentation-derived active pharmaceutical ingredients and finished veterinary…

Fermentation-derived mycoprotein ingredient for sustainable food production

ENOUGH is a Glasgow-based industrial biotechnology company producing a complete protein ingredient made by fermenting fungi with grain-derived sugars. The zero-waste continuous fermentation process is integrated within existing biorefinery infrastructure, enabling large-scale production at competitive economics. Its…

Next-generation targeted protein degradation therapeutics

Amphista Therapeutics is a Cambridge-based biopharmaceutical company developing next-generation targeted protein degradation medicines. Its proprietary platform generates bifunctional small molecule degraders that harness a broader range of the cell's protein-degrading machinery than existing approaches, enabling…

Global licensing and commercialisation of established branded pharmaceutical medicines

Pharmanovia is a specialty pharmaceutical company that acquires, licenses and commercialises established branded medicines, extending their lifecycle for patients worldwide. The company's portfolio spans more than 25 medicines across endocrinology, neurology, cardiovascular and oncology, built through strategic…

Epigenetic reprogramming and senolytic therapeutics for cancer and ageing

199 Biotechnologies is a preclinical-stage biotechnology company developing epigenetic reprogramming and senolytic therapies targeting cancer and age-related disease. Its lead programme applies partial cellular reprogramming to modify the behaviour of glioblastoma cells, reducing malignancy and reactivating natural…

Aquaculture fish health diagnostics and disease monitoring services

PHARMAQ Analytiq Limited is a contract diagnostics organisation providing fish health and disease monitoring services to the UK and Scottish aquaculture sector. Operating from its laboratory at Inverness Campus, the company delivers PCR-based pathogen detection, histopathology, microbiology testing, and environmental…

Global drug discovery and development partnership company

Evotec is a global drug discovery and development company with major UK operations at Milton Park, Abingdon, and Alderley Park, Cheshire. Its Abingdon campus houses over 800 staff spanning target validation, medicinal chemistry, structural biology, in silico design, process development, and biologics manufacturing…

Synthetic biology facility for gene design, engineering and characterisation

The London Biofoundry is a core facility of SynbiCITE, the UK's national Innovation and Knowledge Centre for Engineering Biology, based at Imperial College London's White City Campus. The facility uses advanced robotic systems to provide design, build, test, and learn services for synthetic DNA and engineered…

Sperm DNA fragmentation diagnostics for male fertility assessment

Examen is a Belfast-based diagnostics company specialising in male reproductive health. Its proprietary assay-based technology measures single-strand and double-strand sperm DNA breaks to provide a clinically actionable assessment of male fertility beyond conventional semen analysis parameters. Tests are…

Analytical testing, development and training for pharma and food sectors

Reading Scientific Services (RSSL) is a contract research organisation based at the University of Reading, providing analytical testing, product development, consultancy and training to pharmaceutical, biopharmaceutical and food and consumer goods companies. Its GMP and ISO 17025-accredited laboratories offer…

Programmable gene control platform for advanced cell therapies

Laverock Therapeutics is a biotechnology company developing a programmable gene control platform for the creation of disease-responsive advanced therapies. The platform uses recoded microRNAs to deliver tunable, stable and multiplexed gene silencing within cell therapies, enabling enhanced precision and improved…

Benchtop super-resolution microscopy systems for biological imaging

Northern Light Microscopy is a developer of compact optical microscopy instruments for life science research and drug discovery. Its modular benchtop platform combines structured illumination, total internal reflection and other fluorescence imaging modes to capture high-resolution images of cells and tissues. The…